Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Date:6/12/2013

of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products.  In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates.  We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products.  Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates.  Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
2. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
3. Amgen And Astellas Announce Japan Alliance
4. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
7. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
8. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
9. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
10. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
11. Amgen Announces Webcast of 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... March 31, 2015 According ... and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, ... Incubator, Fume Hood, Centrifuge) - Global Forecast to ... and Chemical Instrumentation Market is expected to reach ... from 2014 to 2019. Browse ...
(Date:3/31/2015)... March 31, 2015 Ryan & Maniskas, ... of directors of Hyperion Therapeutics, Inc. ("Hyperion" or the ... fiduciary duty and other violations of law related to ... Pharma plc in a transaction valued at approximately $1.1 ... and would like to learn more about this class ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2
... patients with acute coronary syndrome being managed with ... ... TOKYO and INDIANAPOLIS, Feb. 21 Daiichi,Sankyo Company, Limited (TSE: 4568) ... the U.S. Food and Drug Administration (FDA) accepted,and designated Priority Review ...
... 21 MonoSol Rx, a drug delivery,company specializing ... it has successfully completed a pilot clinical study ... 5-HT3 receptor antagonist,used in the prevention and treatment ... film formulation of ondansetron was studied against,GlaxoSmithKline,s Zofran ...
Cached Medicine Technology:FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 2FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 3MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 2MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 3
(Date:3/31/2015)... DataEntryOutsourced is pleased to announce ... experts to handle the specialized requirements imposed by food ... nutritional scoring system for a wide array of products. ... nutrition scale data entry services. , DataEntryOutsourced recently ... U.S. Food Nutrition Scale Data Entry." This case study ...
(Date:3/31/2015)... 31, 2015 Indiana Fiber Network, ... Provider, announces that Joink, LLC selected IFN as ... According to Cory Childs, IFN Enterprise Sales Manager, ... targeted at Internet Service Providers, Telecom companies, and ... provides Joink with diverse protected transport from their ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 ... Latinos offered by the VisitandCare.com company, announced today ... Puerto Vallarta. , Embracing the most experienced and ... patients are traveling to obtain elegant, life-altering cosmetic ... seeking reputable plastic surgery clinics in Mexico due ...
(Date:3/31/2015)... For its fourth consecutive year, Survivor Spin, ... cancer survivors, is hoping to raise thousands of dollars ... Loyola Center for Fitness (LCF) in Maywood, IL. ... for the LCF, Nicole Capone, launched the Survivor Spin Relay ... participate in a fun-filled evening of friendly indoor cycling competition ...
(Date:3/31/2015)... March 31, 2015 Smartlink Mobile Systems, ... technology, today announced that Chris Lynch, Managing Director, has ... Venture Conference (SEVC) this week in Charlotte, NC. ... in the southeast region and provides these companies with ... private equity investors. , This year’s conference showcases ...
Breaking Medicine News(10 mins):Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 2Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 3Health News:Smartlink Mobile Chosen to Present at Southeast Venture Conference 2
... in the August 15 issue of the Journal of the ... in Sydney have warned// that a single meal high in ... sufficient enough to cause heart attack. ,In a study ... researchers were shocked to find that three hours after giving ...
... international team that includes a researcher at Duke University Medical ... in people who have no known history of coronary heart ... cholesterol-lowering drug ,The Stroke Prevention by Aggressive ... study, is published in the 10th August 2006 issue of ...
... is not about to deter the organizers of the Dublin ... will go on// , despite the outbreak of the horse ... been fatally hit by EIA, also called swamp fever - ... director Gerry McAuliffe confirmed that the event would begin as ...
... against any pandemic or influenza outbreak, South Australia is ... John Hill said//. The fund would assist in the ... be necessary to fight a potential influenza outbreak. ... outbreak was uncontrollable, nearly 25% of South Australians could ...
... of Canada's postal service and several joint ventures, has ... who are represented by a postal workers' union. Being ... challenges, but like nurses and mechanics, they are at ... that diagnosed musculoskeletal complaints rose from 53 percent in ...
... female foeticides in the state, the Rajasthan government has ... private hospital// for violating the Medical Termination of Pregnancy ... night after a week-long investigation into the three dead ... Fatehsagar Lake Aug 1. ,"We have decided to file ...
Cached Medicine News:Health News:Recurrent Stroke Risk is Minimized by Statin 2Health News:Recurrent Stroke Risk is Minimized by Statin 3Health News:Naturopathic Care and Low Back Pain 2Health News:Naturopathic Care and Low Back Pain 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: